Mathematical model of the impact of a nonantibiotic treatment for Clostridium difficile on the endemic prevalence of vancomycin-resistant enterococci in a hospital setting

Computational and Mathematical Methods in Medicine

Volumn 2012, Issue , 2012, Pages

  Grima, Daniel T ^a   Webb, Glenn F ^b   D'Agata, Erika M C ^c  

^a Department of Data Analytics and Evidence Synthesis   (Canada)

^b VANDERBILT UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; CLOSTRIDIUM; HOSPITALS; SENSITIVITY ANALYSIS;

ANTIBIOTIC THERAPY; ANTIBIOTIC TREATMENT; ANTIBIOTIC-RESISTANT BACTERIA; CLOSTRIDIUM DIFFICILE; HOSPITAL ANTIBIOTICS; HOSPITAL SETTINGS; RELATIVE REDUCTION; VANCOMYCIN-RESISTANT ENTEROCOCCI;

PATIENT TREATMENT;

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COMPARATIVE EFFECTIVENESS; HAND WASHING; HOSPITAL CARE; HOSPITAL PATIENT; INTERMETHOD COMPARISON; LENGTH OF STAY; MATHEMATICAL MODEL; PATIENT ATTITUDE; SENSITIVITY ANALYSIS; SEROPREVALENCE; VANCOMYCIN RESISTANT ENTEROCOCCUS; ANTIBIOTIC RESISTANCE; BIOLOGICAL MODEL; COMPUTER SIMULATION; DRUG EFFECT; ENTEROCOCCUS; HOSPITAL; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; PREVALENCE; PSEUDOMEMBRANOUS COLITIS;

CLOSTRIDIUM DIFFICILE;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; COMPUTER SIMULATION; ENTEROCOCCUS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HOSPITALS; HUMANS; MODELS, BIOLOGICAL; PREVALENCE; VANCOMYCIN RESISTANCE;

EID: 84856393139     PISSN: 1748670X     EISSN: 17486718     Source Type: Journal    
DOI: 10.1155/2012/605861     Document Type: Article

References (29)

1. Barbut F., Corthier G., Charpak Y., Cerf M., Monteil H., Fosse T., Trévoux A., De Barbeyrac B., Boussougant Y., Tigaud S., Tytgat F., Sédallian A., Duborgel S., Collignon A., Le Guern M. E., Bernasconi P., Petit J. C., Prevalence and pathogenicity of Clostridium difficile in hospitalized patients: a French multicenter study Archives of Internal Medicine 1996 156 13 1449 1454 (Pubitemid 26226940)
2. Bartlett J. G., Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism Clinical Infectious Diseases 1994 18, supplement 4 S265 S272
3. Archibald L. K., Banerjee S. N., Jarvis W. R., Secular trends in hospital-acquired Clostridium difficile disease in the United States, 19872001 Journal of Infectious Diseases 2004 189 9 1585 1589 (Pubitemid 38648285)
4. Loo V. G., Poirier L., Miller M. A., Oughton M., Libman M. D., Michaud S., Bourgault A. M., Nguyen T., Frenette C., Kelly M., Vibien A., Brassard P., Fenn S., Dewar K., Hudson T. J., Horn R., René P., Monczak Y., Dascal A., A predominantly clonal multi-institutional outbreak of Clostridium difficile associated diarrhea with high morbidity and mortality The New England Journal of Medicine 2005 353 23 2442 2449 (Pubitemid 41770165)
5. McDonald L. C., Killgore G. E., Thompson A., Owens R. C., Kazakova S. V., Sambol S. P., Johnson S., Gerding D. N., An epidemic, toxin gene-variant strain of Clostridium difficile The New England Journal of Medicine 2005 353 23 2433 2441 (Pubitemid 41770164)
6. Zilberberg M. D., Shorr A. F., Kollef M. H., Increase in adult Clostridium difficile -related hospitalizations and case-fatality rate, United States, 20002005 Emerging Infectious Diseases 2008 14 6 929 931 (Pubitemid 351838602)
7. Al-Nassir W. N., Sethi A. K., Li Y., Pultz M. J., Riggs M. M., Donskey C. J., Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile -associated disease Antimicrobial Agents and Chemotherapy 2008 52 7 2403 2406 (Pubitemid 351915669)
8. Vollaard E. J., Clasener H. A. L., Colonization resistance Antimicrobial Agents and Chemotherapy 1994 38 3 409 414 (Pubitemid 24072223)
9. D'Agata E. M. C., Gautam S., Green W. K., Tang Y. W., High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci Clinical Infectious Diseases 2002 34 2 167 172 (Pubitemid 34028347)
10. Poduval R. D., Kamath R. P., Corpuz M., Norkus E. P., Pitchumoni C. S., Clostridium difficile and vancomycin-resistant Enterococcus: the new nosocomial alliance The American Journal of Gastroenterology 2000 95 12 3513 3515
11. Donskey C. J., Ray A. J., Hoyen C. K., Fuldauer P. D., Aron D. C., Salvator A., Bonomo R. A., Colonization and infection with multiple nosocomial pathogens among patients colonized with vancomycin-resistant Enterococcus Infection Control and Hospital Epidemiology 2003 24 4 242 245 (Pubitemid 36538134)
12. Leber A. L., Hindler J. F., Kato E. O., Bruckner D. A., Pegues D. A., Laboratory-based surveillance for vancomycin-resistant enterococci: utility of screening stool specimens submitted for Clostridium difficile toxin assay Infection Control and Hospital Epidemiology 2001 22 3 160 164 (Pubitemid 32233895)
13. Scheinfeld N., Biggers K., Tolevamer, an orally administered, toxin-binding polymer for Clostridium difficile -associated diarrhea Current Opinion in Investigational Drugs 2008 9 8 913 924
14. Hinkson P. L., Dinardo C., DeCiero D., Klinger J. D., Barker R. H., Tolevamer, an anionic polymer, neutralizes toxins produced by the BI/027 strains of Clostridium difficile Antimicrobial Agents and Chemotherapy 2008 52 6 2190 2195 (Pubitemid 351758558)
15. Garborg K., Waagsb B., Stallemo A., Matre J., Sundy A., Results of faecal donor instillation therapy for recurrent Clostridium difficile -associated diarrhoea Scandinavian Journal of Infectious Diseases 2010 42 11-12 857 861
16. Yoon S. S., Brandt L. J., Treatment of refractory/recurrent C. difficile-associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients Journal of Clinical Gastroenterology 2010 44 8 562 566
17. MacConnachie A. A., Fox R., Kennedy D. R., Seaton R. A., Faecal transplant for recurrent Clostridium difficile -associated diarrhoea: a UK case series QJMed 2009 102 11 781 784
18. A overview of the current status of FDIT Scientific American, November 2011. http://www.scientificamerican.com/article.cfm?id=swapping-ermspage= 3#comments
19. D'Agata E. M. C., Webb G., Horn M., A mathematical model quantifying the impact of antibiotic exposure and other interventions on the endemic prevalence of vancomycin-resistant enterococci Journal of Infectious Diseases 2005 192 11 2004 2011 (Pubitemid 41681900)
20. Muto C. A., Jernigan J. A., Ostrowsky B. E., Richet H. M., Jarvis W. R., Boyce J. M., Farr B. M., SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus Infection Control and Hospital Epidemiology 2003 24 9 362 386 (Pubitemid 36612323)
21. McBryde E. S., McElwain D. L. S., A mathematical model investigating the impact of an environmental reservoir on the prevalence and control of vancomycin-resistant enterococci Journal of Infectious Diseases 2006 193 10 1473 1474 (Pubitemid 43673399)
22. Gbaguidi-Haore H., Legast S., Thouverez M., Bertrand X., Talon D., Ecological study of the effectiveness of isolation precautions in the management of hospitalized patients colonized or infected with Acinetobacter baumannii Infection Control and Hospital Epidemiology 2008 29 12 1118 1123
23. Al-Nassir W. N., Sethi A. K., Nerandzic M. M., Bobulsky G. S., Jump R. L. P., Donskey C. J., Comparison of clinical and microbiological response to treatment of Clostridium difficile -associated disease with metronidazole and vancomycin Clinical Infectious Diseases 2008 47 1 56 62 (Pubitemid 351920588)
24. Gerding D. N., Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection? Clinical Infectious Diseases 1997 25, supplement S206 S210
25. A study to assess the safety, tolerability, effectiveness and absorption of Exodif tablets in Clostridium difficile -associated diarrhea. Trial identifier: NCT00466635, 2011, http://www.clinicaltrials.gov/
26. van Nood E., Speelman P., Kuijper E. J., Keller J. J., Struggling with recurrent Clostridium difficile infections: is donor faeces the solution? Euro Surveillance 2009 14 34
27. Conterno L. O., Shymanski J., Ramotar K., Toye B., Zvonar R., Roth V., Impact and cost of infection control measures to reduce nosocomial transmission of extended-spectrum -lactamase-producing organisms in a non-outbreak setting Journal of Hospital Infection 2007 65 4 354 360 (Pubitemid 46477974)
28. Carmeli Y., Eliopoulos G., Mozaffari E., Samore M., Health and economic outcomes of vancomycin-resistant enterococci Archives of Internal Medicine 2002 162 19 2223 2228 (Pubitemid 35231592)
29. Salgado C. D., Farr B. M., Outcomes associated with vancomycin-resistant enterococci: a meta-analysis Infection Control and Hospital Epidemiology 2003 24 9 690 698 (Pubitemid 37221342)